Suo Y

No ORCID on file · 2 papers in corpus

lab-animal 2025

Knockdown of TOP2A reverses cisplatin resistance in ovarian cancer by inhibiting EMT via ferroptosis mediated by the TP53/GPX4/SLC7A11 axis

Frontiers in immunology ·doi:10.3389/fimmu.2025.1675373

INTRODUCTION: Cisplatin resistance is a major challenge in ovarian cancer therapy, particularly for high-grade serous ovarian cancer (HGSOC). DNA topoisomerase IIα (TOP2A) relates to cancer drug resistance, yet its role and molecular mechan…

other 2024

Application of 3D reconstruction and 3D printing technology in advanced ovarian cancer surgery: a retrospective study

Frontiers in oncology ·doi:10.3389/fonc.2024.1432970

BACKGROUNDS: Advanced ovarian cancer is frequently accompanied by extensive peritoneal metastasis, complicating surgical interventions. This study aims to explore the application of 3D reconstruction and 3D printing technology in the treatm…